Immune remodeling during cervical cancer chemoradiotherapy: temporal biomarkers and the timing of checkpoint blockade

Chenguang Yang, Xuan Song, Hongmei Sun, Min Chen, Xialing Zhu · 2026

Read Immune remodeling during cervical cancer chemoradiotherapy: temporal biomarkers and the timing of checkpoint blockade by Chenguang Yang, Xuan Song, Hongmei Sun, Min Chen, Xialing Zhu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13582198.txt.

Description

Chenguang Yang and four colleagues retell cervical cancer immunotherapy along the treatment timeline, in a review published in two thousand twenty-six. Chemoradiation is curative backbone therapy, and checkpoint drugs have joined it with contradictory trial results. One major trial improved survival; another did not.

Older reviews sorted the tumor's immune environment by cell type using single pre-treatment snapshots. This one organizes serial sampling before, during, and after treatment. Four sequential states emerge, from a virus-shaped baseline through an early priming window driven by DNA damage sensing. The divergence between trials may be a timing problem: the same drug helps or not depending on the immune state it lands in. Scheduling, not selection, is the hypothesis.

Catalog record

CREATORChenguang Yang, Xuan Song, Hongmei Sun, Min Chen, Xialing Zhu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE100 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13582198

Browse the full library · About the Tower of Babel